Acne is the most common skin disorder within the United States, impacting millions of Americans and paving the way for researchers to feverishly develop new therapies and revamp existing treatment options at retail.

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on a drug for acne and a drug for bronchospasm, the company said Monday.

CoverAid has announced that its CoverAid therapeutic concealers now are available exclusively in Ulta Beauty stores nationwide.

Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

Galderma Labs has launched a newly designed pump dispenser for a drug used to treat rosacea, the drug maker said Tuesday.

The Mentholatum Co. has announced that an independent testing group has found its OXY Maximum face wash to be an effective acne treatment at a great value and has endorsed it as a “bargain buy.”

A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

Alba Botanica will be shipping in June its new acne-fighting collection, dubbed Natural Acnedote....

Fighting acne with hair care products? That’s right....